Brainsway (BRSYF) EBITDA Margin (2018 - 2026)

Brainsway (BRSYF) has reported EBITDA Margin for 9 consecutive years, with 20.46% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA Margin rose 897.0% year-over-year to 20.46%; the trailing twelve-month figure through Jun 2026 stood at 17.5% (up 586.0% YoY), and the FY2025 full-year result was 13.51%, up 234.0% from the prior year.
• EBITDA Margin grew to 20.46% in Q2 2026 per BRSYF's latest filing, from 18.11% in the prior quarter.
• Across five years, EBITDA Margin topped out at 20.46% in Q2 2026 and bottomed at 79.86% in Q3 2022.
• Historically, EBITDA Margin has averaged 5.22% across 5 years, with a median of 9.25% in 2024.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin plunged 6456 bps in 2022, then jumped 8400 bps in 2023.
• Over 5 years, EBITDA Margin stood at 71.66% in 2022, then surged by 103 bps to 2.04% in 2023, then surged by 546 bps to 13.16% in 2024, then grew by 20 bps to 15.75% in 2025, then gained by 30 bps to 20.46% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 20.46%, 18.11%, and 15.75% for Q2 2026, Q1 2026, and Q4 2025 respectively.